Current Therapeutic Drugs Treating COVID-19

SARS (Severe Acute Respiratory Syndrome) is a type of acute respiratory syndrome. Coronavirus-2 (SARS-CoV-2) is the virus that causes COVID-19, which has spread globally. However, there is no precise drug that can prevent or treat COVID-19 at this time. Researchers from all over the world are striving to find the most effective ways to treat and prevent COVID-19, from repurposing existing medications to developing novel antiviral therapies. A list of repurposed drugs with significant pharmacological effects and therapeutic efficacies in treating COVID-19 patients might be developed, according to fresh research and clinical data on the virologic SARS-CoV-2.

  • Antivirals
  • Drug Repurposing
Committee Members
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Howard I Maibach

Howard I Maibach

University of California, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - A C Matin

A C Matin

Stanford University, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Consolato M Sergi

Consolato M Sergi

University of Ottawa, Canada
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Autonomous University of Baja California, Mexico
Pharma 2023 Speakers
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Autonomous University of Baja California, Mexico
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Richard Denk

Richard Denk

SKAN AG, Switzerland
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Stefania Raimondo

Stefania Raimondo

University of Palermo, Italy
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Manuel Narvaez Pelaez

Manuel Narvaez Pelaez

University of Malaga, Spain
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Merita Kucuku

Merita Kucuku

Freelance consultant, Albania
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Saliha Koc Aslan

Saliha Koc Aslan

Acibadem Healthcare Group, Turkey

Submit your abstract Today

Watsapp